Scott Gettinger
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers 124
- Lung Cancer Research Studies 66
- Colorectal Cancer Treatments and Studies 49
- CAR-T cell therapy research 22
- Peptidase Inhibition and Analysis 16
- Pulmonary and Respiratory Medicine top 0.1%
- Lung Cancer Treatments and Mutations 161
- Lung Cancer Diagnosis and Treatment 38
- Immunology top 0.5%
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 40
- Genetics top 2%
- Co-authors
- Scott AntoniaRoy S. HerbstJulie R. BrahmerLaura Q.M. ChowKurt A. SchalperNaiyer A. RizviHossein BorghaeiDavid L. Rimm
- Journals
- Journal of Clinical Oncology (92 papers)Annals of Oncology (34 papers)Journal of Thoracic Oncology (29 papers)
- Partner nations
- United StatesSpainItaly
In The Last Decade
Scott Gettinger
253 papers receiving 13.0k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 10.3k
- Pulmonary and Respiratory Medicine 6.8k
- Immunology 2.8k
- Cancer Research 1.7k
- Genetics 471
Countries citing papers authored by Scott Gettinger
This map shows the geographic impact of Scott Gettinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Gettinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Gettinger more than expected).
Fields of papers citing papers by Scott Gettinger
This network shows the impact of papers produced by Scott Gettinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Gettinger. The network helps show where Scott Gettinger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Scott Gettinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | Lifileucel, an Autologous Tumor-Infiltrating Lymphocyte Monotherapy, in Patients with Advanced Non–Small Cell Lung Cancer Resistant to Immune Checkpoint Inhibitorsbreakdown → | 2024 | 62 |
| 3 | 2023 | 8 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 1 | |
| 6 | 2021 | 68 | |
| 7 | 2020 | 83 | |
| 8 | 2019 | 225 | |
| 9 | 2019 | 38 | |
| 10 | Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNAbreakdown → | 2018 | 317 |
| 11 | 2018 | 26 | |
| 12 | 2018 | 3 | |
| 13 | 2017 | 2 | |
| 14 | 2015 | 73 | |
| 15 | 2014 | 154 | |
| 16 | 2014 | 295 | |
| 17 | 2013 | 72 | |
| 18 | 2012 | 142 | |
| 19 | 2012 | 1 | |
| 20 | 2009 | 29 |
About Scott Gettinger
Scott Gettinger is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 258 papers that have together received 13.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (161 papers), Cancer Immunotherapy and Biomarkers (124 papers), Lung Cancer Research Studies (66 papers), Colorectal Cancer Treatments and Studies (49 papers), Cancer Genomics and Diagnostics (40 papers), Lung Cancer Diagnosis and Treatment (38 papers), CAR-T cell therapy research (22 papers) and Peptidase Inhibition and Analysis (16 papers). The work is most often cited by research in Oncology (10.3k citations), Pulmonary and Respiratory Medicine (6.8k citations) and Immunology (2.8k citations). Scott Gettinger has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Scott Antonia, Roy S. Herbst, Julie R. Brahmer, Laura Q.M. Chow, Kurt A. Schalper, Naiyer A. Rizvi, Hossein Borghaei, David L. Rimm, Matthew D. Hellmann and Mario Sznol. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology, International Journal of Radiation Oncology*Biology*Physics and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.